Bright! FRONTEO Official Blog

Bright! FRONTEO Official Blog

CATEGORY
Top > Event / Seminar

[Held on June 6th!13th Economic Security Study Group] EU: Explanation of Corporate Sustainability Due Diligence Directive

Event / Seminar
2022/5/30
 
This webinar will explain the draft Corporate Sustainability Due Diligence Directive, a bill published on February 2022, 2, regarding mandatory human rights and environmental due diligence at the EU level.
In the explanation, in addition to the explanation of the content of the article, how the directive will have legal effect in the member states, the difference between the EU level legal system and the member state level legal system, the EU level legal system I will touch on the process of establishment of the EU and how Japanese companies should accept and respond to this directive.
 
 
【Webinar Summary】

◆ Theme: EU: Explanation of the draft Corporate Sustainability Due Diligence Directive

◆ Date: November 2022, 6 (Monday) 13: 16-00: 17
　
◆ Webinar type: Zoom Webinar
　　
◆ Participation conditions: For companies
Participants from the same industry, individuals, and free e-mail addresses are not allowed to participate.
 
For details of the study sessionplease use this form.
 
 
lecturerNishimura & Asahi 　
Partner Attorney, Co-Representative, Frankfurt & Dusseldorf Office
Tomoya Ishikawa　
 
Registered as a lawyer in 2006. Graduated from the University of Tokyo Faculty of Law in 2005, graduated from the University of Virginia School of Law (LL.M.) in 2015, graduated from the Munich Intellectual Property Law Center in 2016 (LL.M.), and registered as a New York State Lawyer in 2017. He provides advice to many Japanese companies on compliance with global personal information protection legislation and data regulations such as GDPR, and has many related lectures and writing articles.No. 2019 in the overall ranking (corporate vote + lawyer vote) in the "data-related field" of the "lawyer ranking that was active in 1" by Nihon Keizai Inc. Selected in the fields of IT, personal information, and ventures by "Lawyer".
 
 
FRONTEO Inc.　Director/ AI Solution Business Management and President's Office Manager
Mari Yamamoto
 
After joining an advertising agency, he was enrolled in a risk management company.Launched the mental health care business, executed business plans, product development, marketing and sales strategies, and led the company to the top market share in the industry. Appointed as a director in 2014 and listed on the First Section of the Tokyo Stock Exchange in 2017.
Participated in FRONTEO in 2018, became a director in 2020, and is in charge of and directs the president's office and the entire AI solution business.
In the life science AI business, we promoted the development of diagnostic support, disease prediction, and drug discovery support AI systems using the artificial intelligence engine "Concept Encoder", and directed the launch of the world's first medical device using language analysis AI.Take on the challenge of new areas in life science.
In the business intelligence business, we utilize the artificial intelligence engine "KIBIT" to support corporate DX promotion.In the field of economic security as well, we are advocating a change in consciousness together with experts and researchers, and developing intelligence-based solutions for governments, government agencies, and companies.Help companies make strategic decisions with a fact-based approach.
As a top company in the field of natural language analysis, he plans and directs the growth strategy of the AI ​​solution business.
Share this article
<To the previous article
To the next article>
Share this article

Articles in the same category

[5/31 15th Fraud Countermeasures Study Session] [Must-see for compliance personnel] Mass media response in the event of a crisis

[Online seminar held on 5/9] New framework and practical outlook for European foreign investment regulations - Explanation of the European Commission's new regulation proposal and the regulatory environment of major countries -

[Real seminar held on 4/18] “Crisis management proposed by a competition law/consumer law boutique firm” ~Risk management to avoid a “crisis”~

Exploring patient stratification biomarkers for IgA nephropathy using AI: Overcoming bias with AI

Searching for therapeutic targets for pancreatic cancer - I tried using paper search AI -

Parkinson's disease - Analyzing drug discovery targets using paper search AI

Economic Security Symposium co-hosted by FRONTEO x Moody's Analytics Japan on April 4th

Searching for new targets for sporadic ALS using AI: Become friends with AI

[Webinar held on 3/25] Risk of important information leakage of Japanese companies due to cross-border application of discovery and its response

Copyright © FRONTEO, Inc. All Rights Reserved.